Type of security: Stock
Sector: Health Care
Industry: Medical Specialities
The data is delayed by 15 minutes.
Description: BioTelemetry, Inc. provides cardiac monitoring, cardiac monitoring device manufacturing, and cardiac core laboratory services. It operates in three segments: Patient Services, Product, and Research Services. The Patient Services segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. This segment offers Mobile Cardiac Outpatient Telemetry service, which incorporates a lightweight patient-worn sensor attached to electrodes that capture two-channel electrocardiography (ECG) data, measuring electrical activity of the heart, on a compact wireless handheld monitor; event monitoring services to prescribe wireless event monitors, digital loop event monitors, memory loop event monitors, and non-loop event monitors; and a Holter monitor to cardiologists and electrophysiologists. The Product segment focuses on the manufacture, engineering, and development of noninvasive cardiac monitors for healthcare companies, clinics, and hospitals worldwide. This segment offers various devi
|Shares Outstanding||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||1.84%||Sales Growth - Q/Q||-0.5%||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||-4.9%||ROE||-8.96%||ROI|
|Current Ratio||1.54||Quick Ratio||1.43||Long Term Debt/Equity||1.56||Debt Ratio||0.43|
|Gross Margin||56.14%||Operating Margin||-0.09%||Net Profit Margin||-3.32%||Dividend Payout Ratio|
|Cash From Financing Activities||Cash From Investing Activities||-1.04 M||Cash From Operating Activities||-2.07 M||Gross Profit||25.22 M|
|Net Profit||-4.61 M||Operating Profit||470 K||Total Assets||117.16 M||Total Current Assets||42.32 M|
|Total Current Liabilities||27.54 M||Total Debt||23.11 M||Total Liabilities||53.11 M||Total Revenue||43.44 M|
|High 52 week||77.59||Low 52 week||41.92||Last close||41.99||Last change||-1.73%|
|RSI||39.23||Average true range||2.13||Beta||0.77||Volume||232.81 K|
|Simple moving average 20 days||-6.41%||Simple moving average 50 days||-11.19%||Simple moving average 200 days||-28.37%|
|Performance Week||-0.1%||Performance Month||-12.54%||Performance Quart||-17.05%||Performance Half||-43.24%|
|Performance Year||-27.42%||Performance Year-to-date||-29.69%||Volatility daily||2.43%||Volatility weekly||5.43%|
|Volatility monthly||11.12%||Volatility yearly||38.52%||Relative Volume||858.67%||Average Volume||405.31 K|
|New High||New Low|
2020-05-07 16:01:16 | BioTelemetry Inc BEAT Q1 2020 Earnings Call Transcript
2020-05-07 10:22:39 | Edited Transcript of BEAT earnings conference call or presentation 6-May-20 9:00pm GMT
2020-05-06 16:05:10 | BioTelemetry, Inc. Reports First Quarter 2020 Financial Results
2020-05-01 06:40:27 | What Is BioTelemetry's NASDAQ:BEAT P/E Ratio After Its Share Price Rocketed?
2020-04-29 13:13:00 | BioTelemetry, Inc. to Release First Quarter 2020 Earnings Results on May 6, 2020
2020-04-27 09:05:38 | BioTelemetry, Inc. to Move to Virtual-only Annual Stockholder Meeting for 2020
2020-04-22 08:44:12 | Is a Surprise Coming for BioTelemetry BEAT This Earnings Season?
2020-04-16 12:31:04 | BioTelemetry BEAT to Report Q1 Results: Wall Street Expects Earnings Growth
2020-04-15 12:28:58 | Hedge Funds Are Selling BioTelemetry, Inc. BEAT
2020-04-07 10:29:41 | BioTelemetry, Inc. Names Dr. Andrei Stoica Chief Technology Officer
2020-04-03 09:00:46 | Why This Coronavirus Testing Outlet Is Among 4 Key Plays Amid Covid-19
2020-03-05 13:29:02 | Edited Transcript of BEAT earnings conference call or presentation 26-Feb-20 10:00pm GMT
2020-02-26 18:25:11 | BioTelemetry BEAT Q4 Earnings Meet Estimates
2020-02-26 16:05:10 | BioTelemetry, Inc. Reports Fourth Quarter 2019 Financial Results
2020-02-26 13:39:22 | Here's Why We Think BioTelemetry NASDAQ:BEAT Is Well Worth Watching
2020-02-19 12:31:05 | Earnings Preview: BioTelemetry BEAT Q4 Earnings Expected to Decline
2020-02-18 16:05:10 | BioTelemetry, Inc. to Release Fourth Quarter 2019 Earnings Results on February 26, 2020
2020-02-13 12:31:05 | Earnings Preview: BioTelemetry BEAT Q4 Earnings Expected to Decline
2020-02-04 06:18:55 | Should You Worry About BioTelemetry, Inc.'s NASDAQ:BEAT CEO Salary Level?
2020-01-12 08:18:48 | Don't Sell BioTelemetry, Inc. NASDAQ:BEAT Before You Read This
2019-12-20 13:09:54 | Is BioTelemetry, Inc.'s NASDAQ:BEAT ROE Of 11% Impressive?
2019-12-11 12:16:46 | Should You Buy BioTelemetry, Inc. BEAT?
2019-11-28 05:29:19 | Does BioTelemetry, Inc. NASDAQ:BEAT Have A Particularly Volatile Share Price?
2019-11-11 18:40:49 | Edited Transcript of BEAT earnings conference call or presentation 5-Nov-19 10:00pm GMT
2019-11-11 13:12:10 | Mario Gabelli Continues to Buy AbbVie, Axalta
2019-11-05 19:05:12 | BioTelemetry BEAT Beats Q3 Earnings and Revenue Estimates
2019-11-05 16:05:00 | BioTelemetry, Inc. Reports Third Quarter 2019 Financial Results
2019-11-02 09:19:10 | If You Had Bought BioTelemetry NASDAQ:BEAT Shares Five Years Ago You'd Have Made 414%
2019-10-29 14:54:57 | BioTelemetry, Inc. to Release Third Quarter 2019 Earnings Results on November 5, 2019
2019-10-28 09:13:33 | Were Hedge Funds Right About Dumping BioTelemetry, Inc. BEAT?
2019-10-07 08:07:37 | What Does BioTelemetry, Inc.'s NASDAQ:BEAT Share Price Indicate?
2019-09-10 14:30:38 | Is BioTelemetry, Inc.'s NASDAQ:BEAT Capital Allocation Ability Worth Your Time?
2019-09-03 16:05:00 | BioTelemetry, Inc. Named to Fortune Magazine’s 100 Fastest-Growing Companies List
2019-08-15 12:44:20 | BioTelemetry NASDAQ:BEAT Has A Pretty Healthy Balance Sheet
2019-08-05 12:07:32 | BioTelemetry, Inc. Names Manish Wadhwa, M.D., F.H.R.S. Chief Medical Officer
2019-07-31 10:16:15 | Edited Transcript of BEAT earnings conference call or presentation 30-Jul-19 9:00pm GMT
2019-07-30 22:24:32 | BioTelemetry Inc BEAT Q2 2019 Earnings Call Transcript
2019-07-30 20:05:12 | BioTelemetry BEAT Q2 Earnings and Revenues Beat Estimates
2019-07-30 16:05:00 | BioTelemetry, Inc. Reports Second Quarter 2019 Financial Results
2019-07-19 17:58:57 | BioTelemetry, Inc. to Release Second Quarter 2019 Earnings Results on July 30, 2019
2019-07-18 09:58:01 | BioTelemetry BEAT to Report Q2 Earnings: What's in Store?
2019-07-16 14:24:08 | Does BioTelemetry, Inc.'s NASDAQ:BEAT CEO Salary Compare Well With Others?